Lifecore Biomedical News and Resources

Lifecore Biomedical, Inc., a fully integrated contract development and manufacturing organisation (CDMO), has announced the sale of its high-speed, multi-purpose 10-head isolator filler for $17 million. The transaction involves a non-competitive buyer, with $7 million received at closing and the

Lifecore Biomedical, Inc. has announced a new agreement with Nirsum Laboratories, Inc. to support the clinical development of Nirsum’s lead candidate, NRS-033. The collaboration will focus on fill and finish technology transfer, a key component in the development and commercialisation

Lifecore Biomedical, Inc. has been selected by Lindy Biosciences to provide contract development and manufacturing services (CDMO) for the company’s microglassification technology. The partnership aims to streamline the formulation process and scale the technology for commercial manufacturing, with a multi-year

Lifecore Biomedical, Inc., a fully integrated contract development and manufacturing organisation (CDMO), has announced that its high-speed, 5-head isolator filler is now GMP-ready and operational. This new equipment, designed for fill/finish services, will support prefilled syringes, vials, and cartridges, while